Life Sciences 1992-01-01

Non-selectivity of new bradykinin antagonists for B1 receptors.

N E Rhaleb, F Gobeil, D Regoli

文献索引：Life Sci. 51 , PL 125, (1992)

全文：HTML全文

摘要

Two new B1 receptor antagonists, [Hyp3,Thi5,DTic7,Oic8]desArg9-BK and DArg[Hyp3,Thi5,DTic7,Oic8]desArg9-BK were tested in vitro on the rabbit jugular vein and the guinea pig ileum (preparations containing B2 receptors) and on the rabbit aorta (preparation containing B1 receptors) for pharmacological characterization. The results indicate that both compounds are antagonists on both B1 and B2 receptors, are competitive and discriminate between B2A and B2B receptor subtypes.

相关化合物

  • (D-ARG0,HYP3,D...

相关文献：

New highly potent bradykinin B2 receptor antagonists.

1991-09-01

[Agents Actions 34 , 138-141, (1991)]

A new class of bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers.

1992-05-01

[J. Med. Chem. 35 , 1563, (1992)]

Pharmacological evidence for a single bradykinin B2 receptor in the guinea-pig.

1995-10-01

[Br. J. Pharmacol. 116(3) , 2106-12, (1995)]

Pharmacological characterization of a new highly potent B2 receptor antagonist (HOE 140: D-Arg-[Hyp3,Thi5,D-Tic7,Qic8]bradykinin).

1992-01-14

[Eur. J. Pharmacol. 210(2) , 115-20, (1992)]

更多文献...